LISBON Following approval by the European Medicines Agency in June, nerve growth factor eye drops will be available soon on the European market as a breakthrough treatment for neurotrophic keratitis and related conditions.
At the EuCornea meeting, Paolo Rama, MD, a pioneer in the use of nerve growth factor (NGF) for the treatment of corneal ulcers, said he was “immensely satisfied” with this achievement. A breakthrough molecule, which he was able to administer for compassionate use in a limited number of cases, will finally be available for widespread use.
“It (Read more...)
Uncategorized